Publication:
Acute Renal Failure With Acyclovir Treatment in a Child With Leukemia

dc.authorscopusid19933498800
dc.authorscopusid7003365098
dc.authorscopusid18036882700
dc.authorscopusid6506825283
dc.authorscopusid10642354300
dc.authorscopusid32467523200
dc.authorscopusid32467523200
dc.contributor.authorGenç, G.
dc.contributor.authorÖzkaya, O.
dc.contributor.authorAçıkgöz, Y.
dc.contributor.authorYapici, O.
dc.contributor.authorBek, K.
dc.contributor.authorŞensoy, S.G.
dc.contributor.authorÖzyrek, E.
dc.date.accessioned2020-06-21T14:48:50Z
dc.date.available2020-06-21T14:48:50Z
dc.date.issued2010
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Genç] Gürkan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özkaya] Ozan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Açıkgöz] Yonca, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yapici] Oktay, Department of Nuclear Medicine, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Bek] Kenan, Department of Pediatric Nephrology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şensoy] Gülnar, Department of Pediatric Infectious Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Özyrek] Emel, Department of Pediatric Hematology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractAcyclovir is an effective, frequently used antiviral agent. Adverse effects of this drug are well known and are especially seen with high doses and/or dehydration. In this article, we report a 6-year-old boy with leukemia with nonoliguric acute renal failure in normal hydration status after using acyclovir treatment. He had no preexisting renal impairment, and there were no additional symptoms. Dimercaptosuccinic acid radionucleid scyntigraphy and other laboratory findings revealed impairment of proximal tubule function, in addition to distal tubule. We emphasize that renal functions should be monitored carefully during treatment with acyclovir, and asymptomatic nephrotoxicity must be kept in mind. © 2010 Informa UK Ltd.en_US
dc.identifier.doi10.3109/01480540903311076
dc.identifier.endpage219en_US
dc.identifier.issn0148-0545
dc.identifier.issn1525-6014
dc.identifier.issue2en_US
dc.identifier.pmid20307148
dc.identifier.scopus2-s2.0-77949900547
dc.identifier.scopusqualityQ2
dc.identifier.startpage217en_US
dc.identifier.urihttps://doi.org/10.3109/01480540903311076
dc.identifier.volume33en_US
dc.identifier.wosWOS:000275891200013
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherTaylor & Francis Incen_US
dc.relation.ispartofDrug and Chemical Toxicologyen_US
dc.relation.journalDrug and Chemical Toxicologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAcute Lymphoblastic Leukemiaen_US
dc.subjectAcycloviren_US
dc.subjectChildrenen_US
dc.subjectRenal Failureen_US
dc.titleAcute Renal Failure With Acyclovir Treatment in a Child With Leukemiaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files